Case in point
No sooner had I wrapped up yesterday's eTip than I got an email in my Inbox that was a perfect case-in-point about the sorts of mainstream medicine shortcomings Suzanne Somers is attempting to expose in her new book. It was a weekly bulletin from the FDA announcing that, in June, 51 drugs currently on the market required changes to their labeling information due to safety concerns. And these aren't just the types of "new drugs" that the FDA claims it doesn't have time to adequately review. In fact, many of the drugs that needed revised safety warnings are everyday, over-the-counter medications that most people don't think twice about, including 13 different varieties of Advil (some of them children's and infant's formulations to boot). To read the full listing of the 51 drugs that raised the latest red flag, type the following URL into your web browser:
http://www.fda.gov/medwatch/SAFETY/2008/jun08_quickview.htm. In the meantime, keep in mind that these drugs were just the ones cited in June! And the unfortunate reality is that there will undoubtedly be more reports like these in the months to come… Source:
"FDA MedWatch -- June 2008 Drug Safety-Related Labeling Changes for 51 Drugs Now Available on Web," U.S. Food & Drug Administration (FDA) Weekly Digest Bulletin (www.fda.gov/medwatch), 8/3/08 | 
